Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.

In Houston, a 91-year-old sings to his wife of 66 years, while in Louisiana, a 9-year-old raises money for her sister with ...

The device, developed in the U.S. by the Michigan-based Renew Bioscience medical technology company, focuses on restoring vascular health in the brain, improving blood flow and oxygenation. Impaired ...

Dr. Joel Salinas, founder and chief medical officer of Isaac Health, examines the growing dementia crisis as a looming ...

In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The ...

This week’s XBI pullback is healthy. Biotech stocks cannot go up every day. The sector’s recovery off the April lows has been ...